BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Insmed Inc. (INSM) on Thursday reported a loss of $220.5 million in its third quarter.

On a per-share basis, the Bridgewater, New Jersey-based company said it had a loss of $1.27.

The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.19 per share.

The biopharmaceutical developing inhaled treatments for patients battling rare lung diseases posted revenue of $93.4 million in the period, topping Street forecasts. Six analysts surveyed by Zacks expected $93.3 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INSM at https://www.zacks.com/ap/INSM